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Background: According to transtheoretical model (TTM), Stage matched interventions are more effective in quitting. The objective 
of current study was to investigate the effect of individual counseling, line follow‑up, and free nicotine replacement therapy (NRT) 
on smoking cessation in smokers who are in preparation stage of smoking. Materials and Methods: In a randomized clinical 
trial design, through sending the short message system, potential participants in preparation stage of smoking were recruited and 
divided into control (n = 60)and treatment (n = 50) groups. The treatment group received an in‑person counseling, line follow‑up, 
and free NRT. TTM variables trend; pros and cons of smoking, behavioral and experiential processes, temptation, were assessed 
at baseline, 3 and 6 months follow‑up along with point prevalence and continuous abstinence. Results: Continuous abstinence at 
6‑month follow‑up were 3.3% (n = 2) in control group and 46% (n = 23) in the treatment group (x2 = 34.041, P < 0.001). Time × group 
analyses indicated that except cons of smoking (P > 0.05), all TTM constructs had significantly changed; temptation (F = 36.864, 
P < 0.001), pros (F = 12.172, P < 0.001), experiential processes (F = 3.377, P < 0.001), and behavioral processes (F = 11.131, P < 0.001). 
Conclusion: Interventions based on TTM variables increased the quite rate in prepared and motivated people. Our findings suggest 
that interventions through individual counseling along with free NRT and line follow‑up in people who prepare for quitting are 
beneficial for our country.
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Transtheorethical Model (TTM) is one of the models in 
the early 1980s, which was introduced by Prochaska 
and decremented for smoking quit.[7] TTM is one of the 
stage‑based theories and proposes that behavior change 
is not a continuous process but can occur through a 
series of qualitatively different stages. These models, 
consequently, suggest that interventions will be most 
effective when they are tailored to individual’s current 
stage of change. According to these models, three broad 
categories of individuals distinguished:[1] People who 
have not yet decided to change their behavior,[2] people 
who have decided to change, and (three people who are 
already engaged in overt change.[8] The TTM proposes 
that “tailored” interventions, which are taken in to 
account of current stage and the individual has reached 
in the change process, will be more effective than “one 
size fits all” interventions.[8] Results of several studies have 
shown the stage‑based interventions by using different 
strategies to increase the smoking cessation rate.[9‑12]
On the basis of TTM, five different stages of smoking 
behaviors are: (a) Precontemplation (individuals 
INTRODUCTION
According to the WHO reports; 14.2% from 15 to 
64‑years‑old Iran’s population are smokers.[1] The 
Iranian Health Ministry statistics show that cigarette 
consumption in Iran is growing. In 2003, 12% of teen 
13‑15‑years‑old were smokers, that figure has reached 
27% in 2007.[2,3] Meanwhile, about 70% of smokers want 
to quit smoking, and few of them are about 5% who 
receive no help to be succeeded in quitting.[4,5] Results 
of a survey conducted in our country showed that only 
2.4% have managed to quit smoking.[6]
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who are smokers and not intending to quit smoking 
in the next 6 months), (b) Contemplation (individuals 
who are smokers but they try to quitin the next 
6 months), (c) Preparation (individuals who are 
smokers but they have plan to quit smoking in the next 
30 days), (d) Action (individuals who actually quit 
smoking and been abstinent for less than 6 months), 
and (e) Maintenance (individuals have quit smoking and 
they get abstinent for more than 6 months after initial 
quitting).[5] The first three stages are motivational, whilst 
the latter two stages are actionable in nature. Progression 
through the stages is seen as sequential, though relapse 
to an earlier stage can occur.[8,13] The time of occurrence 
changes depends on decisional balance and self‑efficacy, 
which are considered as two intermediate indicators.[14] 
They also explain behavior change strategies through 
10 processes of change that are divided into two categories: 
Experiential process (consciousness raising, dramatic 
relief, environmental re‑evaluation, social liberation, 
and self‑re‑evaluation) and behavioral (Self‑liberation, 
stimulus control, helping relation, counter conditioning, 
and reinforcement management.[15]
Decisional balance is defined as the potential benefits (Pros) 
and costs (Cons) of behavior change.[16] In moving toward 
any decision, individuals weigh the costs and benefits of 
the action being contemplated. In change of behavior, these 
considerations are known as decisional balance, a process 
of cognitively appraising or evaluating the “good” aspects 
or pros, the “less good”aspects or cons of a behavior, the 
reasons to change and not to change that behavior. Lasting 
behavior change is associated with the pros for the behavior 
change increasing and the cons for change decreasing until 
the point of crossing over is reached.[17]
The concept of self‑efficacy is a component of Bandura’s 
social learning theory defined as one’s perceived confidence 
in the ability to perform a specific behavior.[18] In smoking 
behavior; self‑efficacy represents the subjects’ level of 
confidence that they can resist smoking across a number 
of tempting situations.[19] Self‑confidence to resist against 
smoking temptations has tended to decrease among 
precontemplators and get much higher as the smoker acts 
and maintain abstinence.[20]
The first step in quitting is having preparation and 
motivation for quitting.[21] Besides motivation and readiness, 
successful smoking cessation is impressed by nicotine 
dependence. Avoiding the withdrawal symptoms to nicotine 
abstinence is a strong stimulator to continue smoking.[22] In 
one hand, nicotine replacement therapy (NRT) is an effective 
way to overcome the physiological withdrawal symptoms 
because it ameliorates affects and can double smoking 
cessation rate.[23,24] On the other hand, studies have shown 
that telephone follow‑up in both reactive and proactive 
forms are effective in stopping smoking.[25,26]
There is no functional comprehensive policy to control 
smoking in Iran and in this area only one research center 
in Tehran is active. Because the smokers who are in the 
preparation stage committing to and planning for imminent 
change, we focused our interventions in this group. 
Hence, the aim of the current study was to examination 
of individualized counseling, line follow‑up, and nicotine 
replacement on smoking cessation based on TTM constructs.
MATERIALS AND METHODS
Design
Participants were people in preparation stage of smoking 
behavior. The inclusion criteria were having readiness to 
quit; age range were between 12 and 80‑years‑old; not being 
pregnant; and not suffering from MI or CVA (Myocardial 
Infarction or cerebra Vascular Accident) in the last 3 weeks. 
There is no limitation for exclusion criteria.
The research design was a randomized clinical trial with a 
control group.Considering 95% confident coefficient andtest 
power 80%, the sample size was calculated on 46 people in 
both treatment andcontrol groups using this formula:
P was the mean success quit rate in both treatment and 
control group and calculated by:
N
Z p p Z P P P PC C T T=
− + − + −
∆
[ ( ) ( ) ( )]α β2 1 1 1
2
2
P Pc Pt= +
2
Pc was the mean success quit rate in control group and Pt 
was the mean success quit rate considered 0.33 according 
to Erol and Erdogan`s study.[27] Due to the potentially 
dropping rate, we added 10% for both of them, and we 
included 52 people in both groups. For matching purpose, 
we added eight people in the control group. Then, the 
participants randomly allocated into treatment or control 
groups. However, in the follow‑up process, two people of 
the treatment group were dropped from study.
Setting
The study population was all smokers in Gorgan in Golestan 
province, northern of Iran.
Study population characteristics
Demographic profile of the participants (both control and 
treatment group) were shown in Table 1. Of the 110 people, 
60 were in control group and 50 in the treatment group. The 
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participants’ ages ranged between 24 and 65 years, with a 
mean age of 40.50 (SD = 9.72) years. Majority of them (87.3%) 
were married, 98.2% were male, who smoked an average 
of 22.97 (SD = 10.74) cigarettes per day with median length 
of smoking was 20.64 ( SD  = 9.51) years. They had 4.89 
(SD = 15.61), 24h quit attempts in last year. One‑fifth had 
college level and 21.8% had high school graduated, and 
remainders educated 1‑11 years. Slightly over half (51.3%) 
of the sample were workpeople, 12.4% belonged to the 
market, 11.8% were employee, 2.7% farmer, and rest of 
them (21.8%) were unemployed people. The mean score 
for nicotine dependence by means of fagerstrom test for 
nicotine dependence (FTND) was 5.86 (SD = 2.75) and their 
e mean score for motivation was 16.69 (SD = 2.31).
Measures
In order to identify smoking behavior, stage of smoking 
behavior was assessed using 5‑item, Dichotomous 
Scale (yes/no), related to current smoking behavior and 
intention to quit smoking, used by Diclemente et al.[28] The 
decisional balance was assessed by six‑item short form 
questionnaire designed Velicer et al.[29] Participants ratings 
were made on a 5‑point Likert Scale, rating from “not 
important” to” extremely important”. The reliability 
assessed by internal consistency with Cronbach’s alpha 
was acceptable (α = 0.87).
The self‑efficacy Scale to avoid smoking temptation was 
assessed by Velicer et al.[30] short form questionnaires 
containing nine items and assessed participants’ perceptions 
of their ability to refrain from smoking in various situations. 
Participant’s ratings were made on a 5‑point Likert Scale, 
rating from “not all tempted” to“extremely tempted”. The 
self‑efficacy has shown acceptable psychometric properties 
with Chronbach’s alpha = 0.62.
The Persian versions of the stages of change, self‑efficacy 
and decisional balance scales were assessed for validity 
and reliability by using Banville’s method and described 
in elsewhere.[31] Nicotine dependency was assessed by 
FTND.[32] The FTND reliability was acceptable by using 
Chronbach’s alpha = 0.71.
Motivation to cessation was evaluated by using motivational 
test.[33] This test was applied in Persian, by Heydari.[34] The 
test included one question related to the current quitting 
importance and another one to the individual decision about 
giving‑up. These two questions were made on a 4‑point 
Likert Scale, rating from “not important” to “extremely 
important”. The third question associated with the reasons 
for cessation, six reasons. The last question is to ask about 
cessation fore sighting, rating by 6‑point Likert Scale, from 
“extremely successful” to “very little successful”. The range 
of total score was four to 20. The subjects were divided into 
Table 1: Demographic characteristics of participants
Variables Control group (n=60) Treatment group (n=50) Statistics P
Age Mean=40.21(SD=8.94) Mean=40.86(SD=10.67) t=0.732 0.344
Age at smoking initiation Mean=20.50(SD=6.41) Mean=18.20(SD=4.63) t=−2.169 0.032
Longstanding smoker Mean=19.28(SD=8.46) Mean=22.28(SD=10.48) t=1.659 0.100
Cigarettes per day Mean=22.13(SD=9.29) Mean=23.98(SD=12.29) t=0.896 0.372
Fagerstrom score Mean=5.61(SD=2.42) Mean=6.16(SD=3.04) t=1.032 0.305
Motivation to quit Mean=16.33(SD=2.39) Mean=17.12(SD=2.16) t=1.794 0.073
Gender (%)
Male 59 (98.3) 49 (98)
Female 1 (1.7) 1 (2)
Marital status (%)
Married 55 (91.7) 39 (78)
Single 3 (5) 7 (14)
Divorced 2 (3.35) 4 (8%)
Education (%)
1‑5 year 9 (15) 11 (22)
6‑8 year 17 (28.2) 9 (18)
9‑11 year 10 (16.7) 8 (16) x2=3.870 0.795
High school graduated 13 (21.7) 11 (22)
College level 11 (18.4) 11 (22)
Job (%)
Work people 28 (51.7) 25 (50)
Employee 7 (11.7) 7 (14)
Belonging to market 7 (11.6) 7 (14) x2=14.556 0.149
Farmer 2 (3.3) 1 (2)
Unemployed 13 (21.7) 10 (20)
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three motivation subgroups including low,[4‑9] moderate,[10‑15] 
and high.[16‑20]
Procedure
In order to reach on potential respondents we sent the 
message through the short message system (SMS) of cell 
phone for 40,000 cell phone numbers in three periods of 
time, separately. These phone numbers were selected from 
350,000 numbers by a private firm which activates numerous 
SMS. Meanwhile, 100,000 of the advertising materials in A4 
size were distributed in all part of the city. The contents of 
the two methods were free in cost calls to smoking‑cessation 
program that it was recruiting for quitting intervention. 
The respondents were asked to respond to the questions in 
their own privacy and were guaranteed of their responses.
To get the quitting rate, we used the self‑reported “point 
prevalence abstinence” in 3‑and 6 months follow‑ups from 
baseline; not one puff of smoke during the past 7 days 
for preparation stage. The continuous abstinence for the 
maintenance stage was defined as not one puff of smoke 
during the past 6 months.[35]
The procedures were approved by the Isfahan University of 
Medical Sciences Institutional Review Board and registered 
in Iranian Register of Clinical Trials (IRCT201011025074N1). 
Meanwhile, the procedure followed the ethical principles 
outlined in the 1975 Helsinki Declaration. Prior to the study, 
all the participants provided written, informed consent.
Interventions
Five sessions of personal counselling, that will take about 
45 min. Using free nicotine chewing gum for 2 months along 
with phone line follow‑up, including 2 times in the 1st week 
with the nicotine chewing gum use. Then, continued once 
in a week for3 months, and finally quarterly until the end 
of the 6th month.
Two milligrams of nicotine chewing gum were used based on 
subject’s nicotine dependency for 2 months, five consulting 
sessions along with one booklet. The using dose of chewing 
nicotine gum was the basis on the subject’s nicotine 
dependency according to Fagerstrom test that divided 
into three groups: Low dependency group (score 0‑3), 
middle dependency (score 4‑6), high dependency.[8‑10] Low, 
middle, and high depended people of the treatment group 
received the maximum daily gums by 6, 9, and 12 gums, 
respectively. For all three groups’ nicotine chewing gum 
doses were tapered 2 gums biweekly. Counseling sessions 
were included preparation for cessation and the exact quit 
date, nicotine withdrawal symptoms and how to deal with 
them, tempting situations and their control, stress and its 
management, weight control and nutrition after quitting. All 
of these were placed in a booklet and submitted for them. 
A participant in the control group did not receive any drug 
or intervention except for recommendations for cessation.
Analysis
Data were analyzed using SPSS version 15.0.Descriptive 
statistics were used to demographic variables and quite rate. 
Normal distribution was confirmed by the Kolmogorov–
Smirnov test for continuous variables. In analyses with 
TTM variables as the outcome, repeated measure analysis 
was conducted for deviations over the time (baseline, 3 
and 6 months follow‑up) and two factors (time × group) 
repeated measures analysis of variance was performed 
to examine the effects of group (treatment, control) 
and time (baseline, 3 and 6 months follow‑up) on each 
dependent variable. ANCOVA and Chi‑square were tested 
for group differences. Due to Mouchly`s test, sphericity 
assumption was not satisfied, except in cons of smoking, 
we used Greenhouse‑Geisser for adjusting degree of 
freedom. ANCOVA and Chi‑square were tested for group 
differences. Independent samples t‑test were calculated for 
TTM variables difference between quitters and smokers. 
The Paired‑Samples t‑test was computed the differences 
between values of the TTM variables for each group, 
whether the average differs from baseline. P value of less 
than 0.05 was considered statistically significant.
RESULTS
Abstinence rate
Past‑week abstinence from smoking was different in control 
and treatment group.This amount at 3‑month follow‑up 
was 10% in control group and 64% in the treatment 
group (x2  = 34.114, P  < 0.001). At 6‑month follow‑up, it 
was 13.3% in control and 60% in treatment (x2  = 32.021, 
P < 0.001). Based on self‑report point prevalence abstinence 
the result indicated that in 3‑month follow‑up just 2 (3.3%) 
people were in action stage in control group but, this rate 
was 30 (60%) for people in treatment group (x2 = 44.592, 
P  < 0.001). In 6‑month follow‑up the point prevalence 
for control group was constant 2 (3.3%) but for treatment 
group was 26 (52%) (x2 = 33.881, P < 0.001). The continuous 
abstinence based on transtheoretical model stage of change 
on the cut‑off for the maintenance stage (183 days) was 
23 (46%) (x2  = 34.041, P  < 0.001)for treatment group and 
none for the control group. The progression and regression 
of the participants in two groups on the 3 and 6‑month 
follow‑up, reported in Table 2. At 6‑month follow‑up, the 
total regression rate was 29 (48.4%) in control people and 
12 (24%) in treatment people.
Transtheorethical model constructs
According to repeated measure analysis of variance 
(RM‑ANOVA) the results of study in line of TTM variables 
indicated that in treatment group at 6‑months follow‑up, 
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all constructs had significant differences with baseline 
except cons of smoking. But in control group at 6‑month 
follow‑up, these variables were not significantly different 
with baseline [Table 3]. Figure 1a, shows that in treatment 
subjects’ temptation to smoking decreased significantly 
3 and 6 months after interventions, F (1,50) =  30.215, 
P < 0.001, h2 = 0.44, pros of smoking decreased significantly 
in the treatment group over time but no significant 
deviation in control group, F (1,413) = 18.601, P  < 0.001, 
h2 = 0.37, [Figure 1b]. In line with cons of smoking, both 
two groups were not having any differences in baseline 
and over the time (P > 0.05) [Figure 1c]. Further, treatment 
people were used significantly from behavioral process, 
F (1,359) = 9.239, P < 0.001, h2 = 0.21, than experiential process, 
F (1,687) = 5.890, P < 0.001, h2 = 0.26, [Figure 1d and e].
Tests of repeated measure analysis of variance 
related to time  × groups indicated that except cons of 
smoking (P  > 0.05), all TTM constructs had significantly 
changes; temptation, (F (1,562) =  36.864, P  <  0.001, 
h2  = 0.23, pros F (1,473) = 12.172, P  < 0.001, h2 = 0.12, 
cognitive processes, F (1,797) = 3.377, P < 0.001, h2 = 0.05, 
and behavioral processes F (1,474) = 11.131, P  < 0.001, 
h2 = 0.13, [Table 4]. The paired‑samples t-test results showed 
that in control groups there was no differences within the 
control group except in pros of smoking in 3 month and 
6month follow‑up (t = 2.481, P < 0.05). Within treatment 
group there were no significant differences in experiential 
processes between baseline and 3‑month follow‑up, as well 
as in behavioral processes between 3 month and 6 month 
follow‑up (P > 0.05). However, the cons of smoking change 
was not significant in both groups [Table 5].
Independent samples t‑test were calculated between 
succeed in quitting and those who were till smoking on 
the TTM constructs for 3 and 6 month follow‑up within 
treatment group and showed some differences [Table 6]. In 
total, Quitted had higher scores on the behavioral process 
in both 3 and 6 months follow‑up (t = −8.401, P < 0.001 and 
t = −10.407, P  < 0.001).But, higher scores on experiential 
Table 2: Regress, constant, and progress in 3 and 6-month follow-up 
3-month follow-up 6-month follow-up
Group Regress* Constant Progress• x2 P Regress Constant Progress x2 P
Control (%) 18 (30) 40 (66.7) 2 (3.3) 29 (48.4) 29 (48.4) 2 (3.2)
44.592 <0.001 34.041 <0.001
Treatment (%) 8 (16) 12 (24) 30 (60) 12 (24) 12 (24) 26 (52)
*Relapse to previous stage/stages; No change; •Move toward action stage at 3‑month follow‑up, or both action or maintenance stages at 6‑month follow‑up
Figure 1: Transtheorethical model variables deviations over the time. (a) Temptation trends over the time, (b) Pros trends over the time, (c) Cons trends over the 
time, (d) Experiential process trends over the time, (e) Behavioral process trends over the time
(a)
(e)(d)
(c)(b)
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process only at 6‑month follow‑up (t = −2.329, P < 0.05). 
Further, they had perceived lower pros of smoking over 
the time (t = 5.026, P < 0.001 and 4.116, P < 0.001). There 
were no differences between smokers and nonsmokers 
in cons of smoking in 3‑month (t = 0.877, P = 0.155) and 
6‑month (−0.436, P  = 0.665). Temptation to smoking was 
lower in the quitted people than in smokers (t  = 7.422, 
P < 0.001and t = 10.407, P < 0.001).
There were no differences between quitted people and 
smokers in FTND scores, quit attempt in past year, number 
of cigarettes daily consumed, education level, job profile, 
and marital status both at 3 and 6 months follow‑up.
DISCUSSION
To our knowledge, this study was the first work that 
included all TTM variables in smoking cessation. The 
result indicated that the continuous abstinence rate based 
on the maintenance stage was 46% in the treatment group. 
This finding emphasis on the role of tailored intervention, 
individual counseling, and NRT as well as. According to 
TTM, stage matched intervention increase the abstinence 
rate in smokers, especially who were in preparation stage.[8] 
Because the individual in preparation stage motivated to 
quitting, their success in quitting could be enhanced by 
NRT, line follow‑up, and in person counseling. Nicotine is 
addictive material that could be influenced any successful 
quitting by its withdrawal symptoms. Hence, including 
NRT for overcoming on psychological and physiological 
symptoms is very important issue. Several studies have 
shown that nicotine dependency role in the success or 
failure of smoking cessation and that using NRT, especially 
Table 4: Repeated measure analyses of variance (group, time, and time×group) for transtheoretical model variable
TTM constructs Groups Baseline 3-month 6-month Time×Group
h2 F
Temptation Control 3.69±0.68 3.77±0.64 3.77±0.71 0.23 36.864**
Treatment 3.81±0.78 3.17±0.92 2.92±1.10
Pros Control 2.91±1.06 2.91±1.03 2.82±1.01 0.12 12.172**
Treatment 2.41±0.99 1.97±0.88 1.84±0.50
Cons Control 3.81±0.78 3.76±0.73 3.68±0.63 0.02 1.361
Treatment 3.93±0.83 3.94±0.73 3.926±0.71
Experiential processes Control 3.51±0.76 3.54±0.50 3.49±0.54 0.05 3.373
Treatment 3.58±0.66 3.56±0.49 3.28±0.48
Behavioral processes Control 2.98±0.72 2.83±0.62 2.87±0.71 0.13 11.131**
Treatment 2.99±0.70 3.58±0.88 3.53±1.04
*P<0.05; **P<0.001; TTM= Transtheoretical model
Table 3: Deviation of transtheorethical model variables 
according to repeated measure analysis of variance in 
control and treatment group
TTM construct Baseline 
(M±SD)
3-month 
(M±SD)
6-month 
(M±SD)
h2 F
Temptation
Control 3.69±0.68 3.77±0.64 3.77±0.71 0.06 2.215
Treatment 3.81±0.78 3.17±0.92 2.92±1.10 0.44 30.215**
Pros
Control 2.91±1.06 2.91±1.03 2.82±1.01 0.09 2.252
Treatment 2.41±0.99 1.97±0.88 1.84±0.50 0.37 18.601**
Cons
Control 3.81±0.78 3.76±0.73 3.68±0.63 0.06 3.510
Treatment 3.93±0.83 3.94±0.73 3.926±0.71 0.05 0.97
Experiential process
Control 3.51±0.76 3.54±0.50 3.49±0.54 0.01 0.268
Treatment 3.58±0.66 3.56±0.49 3.28±0.48 0.26 5.890*
Behavioral process
Control 2.98±0.72 2.83±0.62 2.87±0.71 0.04 1.431
Treatment 2.99±0.70 3.58±0.88 3.53±1.04 0.21 9.239**
*P<0.05; **P<0.001; M= Mean; TTM= Transtheoretical model
Table 5: Paired-samples t-test within groups for transtheorethical model constructs
TTM variables Groups Baseline mean±SD 3-month mean±SD T* P 6-month mean±SD T** P
Temptation Control 3.69±0.68 3.77±0.64 1.861 0.068 3.77±0.71 −0.150 0.882
Treatment 3.81±0.78 3.17±0.92 5.264 <0.001 2.92±1.10 3.108 0.003
Pros Control 2.91±1.06 2.91±1.03 000 1.000 2.82±1.01 2.481 0.016
Treatment 2.41±0.99 1.97±0.88 3.813 <0.001 1.84±0.50 2.161 0.036
Cons Control 3.81±0.78 3.76±0.73 0.755 0.455 3.68±0.63 1.397 0.168
Treatment 3.93±0.83 3.94±0.73 −0.158 0.875 3.926±0.71 −0.255 0.785
Experiential processes Control 3.51±0.76 3.54±0.50 −0.473 0.638 3.49±0.54 0.802 0.426
Treatment 3.58±0.66 3.56±0.49 0.149 0.882 3.28±0.48 3.826 <0.001
Behavioral processes Control 2.98±0.72 2.83±0.62 1.577 0.120 2.87±0.71 −0.522 0.604
Treatment 2.99±0.70 3.58±0.88 −3.636 <0.001 3.53±1.04 0.466 0.643
*Parired‑samples t‑test between baseline and 3‑month follow‑up; **paired‑samples t‑test between 3‑month and 6‑month follow‑up
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in people with high nicotine dependence in the first few 
weeks of smoking cessation has a great impact.[36,37] In the 
meantime, the offering of free NRT should be considered 
because the economic barrier to NRT is one of the barrier 
that can alter the quit attempts and decrease the motivation 
for cessation. Alberg et al.[38] reported that free transdermal 
nicotine patches provision increased quit rate from 38% to 
56%. Meanwhile, referred to smoking cessation in a period 
of 18‑month increased by 37%.
The study conducted by Nohlert and colleagues showed 
that the success rate of continues abstinence rate in the 
group that had received high‑intensity counseling twice 
the depth of a group that had received only short‑term 
counseling.[39] Besides, phone calls follow‑ups and 
in‑person counseling provide the social support for 
smoking abstinence. Some studies have shown that 
providing telephone counseling can cause to help quit 
smoking. McAlister et al. [40] study’s estimated that 
telephone counseling services had about 8% more quit 
rate than self‑help group and was 1 year cost‑effective 
in smoking cessation. Another study results showed the 
effectiveness of quit lines as auxiliary method, if it is to 
be used along with health care system.[25] Heydari et al.[41] 
study on efficacy of telephone quit‑line for smokers in 
Iran showed the sustained abstinence rate after 1, 3, 6 
and 12 months was 59%, 41%, 31% and 18%; respectively. 
However, our proactive calling provided access to 
counseling and was helpful in quit processing.
We did found a considerable effect size related to TTM 
variables in treatment group at two follow‑up measurements. 
These results confirmed the role of behavioral counseling, 
social support and NRT to succeed quitting rate.
The current study showed that non‑smokers use more 
behavioral process and some cognitive process like 
consciousness raising, social liberation, and environmental 
re‑evaluation in their quitting process. Smokers reported 
more relapse and greater temptation and little self‑efficacy 
to smoke, especially in negative/affective situations. 
Furthermore, the pros of quitting were lower in quitted 
person but cons of smoking were not different between 
smokers and non‑smokers. This could be explained by 
high perceived costs of smoking in two groups. The 
smokers perceived more benefits and costs from smoking 
simultaneously but, non‑smokers perceive low benefit 
and higher costs of smoking. Furthermore, the temptation 
rate decreased and self‑efficacy increased over the time. In 
consistent with our findings Fang et al.[42] reported that their 
intervention resulted in greater self‑efficacy, and greater 
pros of quitting over time but, in contrast to our study their 
participants reported fewer cons of quitting at 3‑month 
follow‑up. In this area, it should be noted that the cons and 
barriers of smoking in both control and treatment groups 
were high in baseline and not changed in post baselines. In 
the study, the minimal intervention strategy was influenced 
only the intention to quit and self‑efficacy only for high 
educated patients but, did not increased pros of quitting 
and pros of smoking.[43]
The results showed that people who quit are more likely to 
Table 6: Transtheorethical model variables differences between quitted and smokers at 3 and 6 months follow-up
Model variables 3-monthfollow-up 6-monthfollow-up
Quitted 
mean±SD
Smokers 
mean±SD
t P Quitted 
mean±SD
Smokers 
mean±SD
t P
Consciousness raising 4.18±0.53 3.22±0.78 −5.146 0.001 4.10±0.47 2.68±0.73 −7.963 0.001
Dramatic relief 2.86±0.70 3.47±0.95 2.593 0.013 2.41±0.68 3.94±0.83 2.431 0.019
Self‑re‑evaluation 2.93±0.72 3.62±0.93 2.944 0.005 2.56±0.89 3.03±0.71 2.065 0.044
Environmental re‑evaluation 3.51±0.67 3.57±0.94 0.254 0.801 4.15±0.77 3.46±0.66 −3.387 0.001
Social liberation 4.41±0.50 3.80±0.67 −3.672 0.001 4.02±0.69 3.59±0.69 −2.173 0.035
Experiential process 3.58±0.37 3.54±0.64 −0.300 0.765 3.45±0.33 3.14±0.55 −2.329 0.024
Self‑liberation 4.05±0.71 3.85±0.85 −0.896 0.375 4.69±0.39 3.57±0.91 −5.453 0.001
Helping relationship 3.80±0.61 2.62±0.75 −6.048 0.001 4.00±0.39 2.61±0.80 −7.551 0.001
Counterconditioning 4.21±0.77 2.02±0.83 −9.776 0.001 4.32±0.35 2.18±0.92 −10.480 0.001
Stimulus control 4.05±0.71 3.85±0.85 −0.896 0.375 5.00±0.00 2.14±1.05 −12.951 0.001
Reinforcement management 3.96±0.61 3.20±0.95 −3.467 0.001 4.39±0.29 3.14±0.80 −6.985 0.001
Behavioral process 4.13±0.53 2.75±0.62 8.401 0.001 4.48±0.18 2.73±0.74 −10.407 0.001
Pros of smoking 1.55±0.46 2.60±0.98 5.026 0.001 1.37±0.33 2.24±0.96 4.116 0.001
Cons of smoking 3.93±0.72 3.96±0.76 0.877 0.155 4.01±0.72 3.92±0.71 −0.436 0.665
Decisional balance 2.37±0.74 −1.36±1.38 3.353 0.002 −63±0.80 −1.97±1.22 10.490 0.001
Positive/social temptation 2.58±0.57 3.90±0.91 6.230 0.001 1.91±0.59 3.64±0.94 7.564 0.001
Negative/affective temptation 3.20±0.67 4.55±0.53 7.505 0.001 2.56±0.46 4.35±0.69 10.490 0.001
Habit/craving temptation 2.11±0.67 3.53±0.88 6.333 0.001 1.33±0.34 3.29±0.93 9.550 0.001
Total temptation 2.63±0.58 3.99±0.70 7.422 0.001 1.93±0.34 3.76±0.77 10.407 0.001 
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use behavioral process than smokers. According to TTM, 
smokers who are in the early stages apply more cognitive 
and experiential processes but when they started to quit 
and moving to later stages, they use behavioral processes.[44]
In contrast to TTM, quit participants reported more 
consciousness raisings and social liberation than smokers. 
In this area, Glanz et al.,[45] reported that social liberation 
has unclear relationship to the stages. In line with 
consciousness raising, it could be explained that people 
who quit may increase their awareness about smoking and 
its complications. However, others reported that there was 
not consistent relationship between the stages of change and 
processes that used and suggested that more basic research, 
especially longitudinal studies are need.[15,46‑48]
Our research encountered with some limitations to its 
generalizing. First, quit rate was based on participants 
self‑report, and not verified biochemically. Second, its 
inclusion criteria was only smokers who were in preparation 
stage. Third, it’s small sample size and follow‑up until 6‑month. 
Further researches should be useful that included smokers in 
earlier stage like precontemplation and contemplation.
CONCLUSION
Our findings revealed that uses of individual counseling, 
telephone follow‑ups, and free NRT in motivated and 
prepared people to quit, increased the continuous 
abstinence rate. Hence, it is recommended that to establish 
counseling centers in primary care systems, along with 
free provision of NRT, and access to quit line. Definitely, 
it could be possible to change the current tobacco control 
policy by policymakers.
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